Revance Therapeutics Inc (RVNC)

[vinmantoo]

Has this Jeuveau phase II study been discussed. They claim 6 months or longer Glabellar line improvement. Was this because they used a different, less stringent metric for improvement than RVNC? It seems to be a very small number of patients in the high dose arm and the metics seem vague as they lump together 1pt improvement or greater. No separation into effect of patients with severe wrinkles or with moderate wrinkles for each arm.

https://s29.q4cdn.com/603291515/files/doc_events/2023/Jan/30/updated/2023.01.30-analyst-call-extra-strength-phase-ii-study-interim-results-website.pdf